Advocacy is woven into the fabric at Daiichi Sankyo US, and leading the way for patient voices is Gissoo DeCotiis, Global Head of Advocacy & Strategic Relations. Two decades ago, Gissoo found her calling caring for her brother through his kidney cancer experience. She continues to honor his memory with every patient she helps to feel informed, heard and supported. ?? Read on:?https://bit.ly/4h9oAdK #DSProud?
Daiichi Sankyo US
制药业
Basking Ridge,NJ 194,001 位关注者
We create life-changing solutions for patients.
关于我们
At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.us. See our community guidelines here: https://bit.ly/4fLkZS8
- 网站
-
https://daiichisankyo.us/
Daiichi Sankyo US的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Basking Ridge,NJ
- 类型
- 上市公司
- 领域
- Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo group of companies and is focused on the development of oncology therapies and specialty medicines.、Oncology和Specialty Medicine
地点
-
主要
211 Mt. Airy Road Basking Ridge
US,NJ,Basking Ridge,07920
Daiichi Sankyo US员工
-
Jak (J. C.) DeTemple
Top Talent Executive Recruiter to the Biotech/Pharma Industry Leadership Superstars! Top Talent Sourcing Guru! Talent Acquisition & Retention…
-
Hayes Williams
Global Head of Data Governance at Daiichi Sankyo, Inc.
-
Desmon Swanston
-
Joseph Prikazsky
Pharma/Biotech Financial Professional
动态
-
Helping create new standards of care and better futures through medicine as President & CEO of Daiichi Sankyo, Inc. and Global Head of the Daiichi Sankyo Oncology Business
Sharing my first “external” contribution to WSJ CEO Council around the heavily debated topic (and opportunity) of generative AI and its potential impact on the future of healthcare. Great perspectives by members Brian Becker, Revathi Advaithi and Joerg Moeller, M.D. One thing we can all agree on is that the human element –?the empathy and compassion we bring to patients – will always remain an essential part of harnessing machine learning. #WSJCEOCouncil #CEOExcellence
We asked four of our WSJ CEO Council members: 'What are some of the real-world ways generative AI has added material value to your business?' Here's what Ken Keller of Daiichi Sankyo US, Joerg Moeller, M.D. of BenevolentAI, Brian Becker of RSM US LLP and Revathi Advaithi of the Flex said. #WSJCEOCouncil #CEOExcellence Apologies in advance for the small print, but it can also be found in the print edition of The Wall Street Journal and in plain text below. “Resources at Daiichi Sankyo, machine-learning based or not, are dedicated to delivering innovative medicines swiftly. Time is critical for people with cancer. GenAI accelerates progress by providing efficient first drafts of anything from clinical protocols to data analyses. Shaving o time here and there brings the starting gate closer to the finish. We expect that soon, learning algorithms will help identify appropriate dosing and predict safety and ecacy outcomes. But human quality assurance, critical thinking and empathy will always remain essential.” Ken Keller Chairman of the Board, President and CEO Daiichi Sankyo, Inc. “The pharma and biotech industry still faces over a 90% failure rate in drug development, and 9,000 diseases lack effective treatments.? By integrating data from a vast range of sources—from genetics to clinical trials across all disease areas—generative AI can help us uncover new insights, identify new drug targets and improve success rates while reducing timelines. Patient-driven disease modelling focuses on mechanisms driving tailored medicines, while AI’s agnostic approach helps us overcome challenges even top scientists face.” Dr. Joerg Moeller CEO BenevolentAI “Generative AI offers a unique opportunity to reimagine how we work. It’s not about the technology itself, but about how it can unlock new ways of thinking and working. My advice: Think about AI as a catalyst for growth and focus on how it can complement your people, not replace them. It’s more about AI technology empowering human insight and creativity to solve challenges in new ways that neither humans nor technology could do separately on their own.” Brian Becker Managing Partner and CEO RSM US LLP “When deployed thoughtfully, AI fosters innovation, streamlines processes, reduces costs and enhances productivity. Using AI, we leverage our supply chain and manufacturing data to reduce waste and help make better decisions based on suppliers, logistics and operating conditions. We gain contextual insight from our data that enhances our ability to navigate our customers through a complex, dynamic global environment. We also manufacture data center solutions to help solve the growing power and compute demands as AI becomes ubiquitous.” Revathi Advaithi CEO Flex
-
Our experiences are not universal. Representation matters.?? We make the biggest impact when every employee's voice has a place at the table.?? ? At Daiichi Sankyo US, we understand that each unique voice within our Latin community deserves to be seen, heard, and valued. Francisco Rivera, Senior Payroll Analyst, is proud of his Guatemalan heritage and knows firsthand how important it is for Latin cultures to be accurately represented and understood.? ? “One thing that makes me proud to be Latino is our diversity. There’s no such thing as a universal Latino experience. That’s why I believe representation is so important. To truly close gaps in equality, everyone needs to be represented.”? ? ??Click for more on how we foster inclusion: https://lnkd.in/eczSwS_s #DSProud #HispanicHeritageMonth #Inclusion #Belonging?
-
Taking “A Journey Through Japan,” our annual employee appreciation event celebrated both our rich heritage and our commitment to our people. ? ?? From feeling the energy of Taiko drummers (watch with sound on! ??) to exploring traditional Japanese arts—like origami and calligraphy—and finding peace in the Zen Garden, the day was a perfect blend of culture and camaraderie. ? More than just a festive gathering, it’s events like this that exemplify our commitment to work-life balance and mental well-being. It’s just one of many ways that Daiichi Sankyo US enables employees to unwind, reset and reconnect so that we can collectively come back stronger—for each other and the patients we serve. ? How do you prioritize mental health at work? ?? Interested to learn more? https://lnkd.in/eM8E7Rb9 #DSProud #Culture #MentalHealth #WorldMentalHealthDay
-
By embracing the diversity within our team, we unlock new perspectives that help us better serve patients worldwide.?? ? At Daiichi Sankyo US, celebrating Hispanic Heritage Month means recognizing the diversity within Hispanic and Latin cultures and each of our unique lived experiences. For Amanda Hudson, Digital Communications Manager, her Puerto Rican identity is a source of pride, reminding us that there’s no single way to be Latina.? ? “Being a good ally means checking your assumptions. Someone might not look Latin or have a Latin sounding name, but that doesn’t detract from who they are.? I am a proud Boricua, and I am absolutely Boricua enough."? ? ??Click for more on how we champion inclusion: https://lnkd.in/eczSwS_s?? ? #DSProud #HispanicHeritageMonth #Inclusion #Belonging?
-
We’re pushing the boundaries of research to find new biomarker targets. Why? It's our mission to continuously innovate and find solutions that meet individuals' unique needs, ensuring the best possible outcomes. Discover how biomarker testing personalizes treatment and why advancing awareness of this critical component of cancer screening is essential: https://bit.ly/4dDH4jC
-
Breast cancer accounts for 30% of all cancer diagnoses in women each year in the United States.?? ? ?? Discover how we amplify the efforts of our partners—like?The Breasties, Living Beyond Breast Cancer, Unite for HER, and Young Survival Coalition — to ensure that everyone impacted by #BreastCancer feels seen, heard, and most importantly, supported: https://bit.ly/4d2IJiX #BreastCancerAwarenessMonth
-
#BREAKINGNEWS: The FDA has granted Priority Review of our #ADC for the treatment of certain patients with metastatic #BreastCancer. Click the image for more information on the filing and what it may mean for patients impacted by these cancers.
-
At Daiichi Sankyo, Compassion for Innovation and Compassion for Patients? is more than a tagline – it’s at the core of everything we do. Watch how these two elements converge in the latest episode, “Where Craft Meets – Patients.”? Our Global Head of Advocacy & Strategic Relations Gissoo DeCotiis explores the critical role of translating science into a “language patients not only understand but can then feel empowered to utilize to become more engaged in their care and treatment plans.” Join us exclusively on the Daiichi Sankyo US YouTube channel as one of our R&D leaders, Dalila Sellami brings Gissoo’s craft of Translation to life. https://bit.ly/4efbmdl #WhereCraftMeets #oncology #cancer #innovation #PatientAdvocacy
-
????From fielding ground balls to finding common ground, baseball bridges the gap. For 20+ years, the Daiichi Sankyo Rising Suns baseball team has competed in the “Nippon Club President’s Cup” Annual Baseball Tournament helping to build connections and trust between our Japanese ex-pats working in the US and local colleagues through love of the sport. ?? As the regular baseball season comes to a close, we celebrate our Rising Suns and their shining example of teamwork and camaraderie! ?? #DSProud #culture #baseball